The United States boasts a thriving pharmaceutical industry, particularly when it comes to the production of active pharmaceutical ingredients (APIs). Among these APIs, tirzepatide has gained significant prominence due to its potential in treating type 2 diabetes and other metabolic disorders. Numerous companies have emerged as key manufacturers of

A Contract Development and Manufacturing Organization (CDMO) specializing in GMP peptides provides a comprehensive suite of services to support the development and production of biopharmaceutical peptides. These organizations possess state-of-the-art facilities and skilled personnel to ensure fulfillment with stringent regulatory requirements, such